Skip to content

XMED: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

XMED

BE 0630.634.810
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€7,870
2024 · -€103,436+€95,566
Equity
-€638,978
2024 · -€631,107-€7,870
Cash
€27,738
2024 · €22,263+€5,476
Balance sheet total
€136,494
2024 · €154,317-€17,822

Largest movements

2024 to 2025
Assets
  • Stocks and contracts -€9,299

    down €9,299 (-12.4%), from €74,950 to €65,651

  • Receivables within one year -€8,553

    down €8,553 (-22.5%), from €38,007 to €29,454

    of which Trade receivables: -€11,124

  • Cash +€5,476

    up €5,476 (+24.6%), from €22,263 to €27,738

    mainly Other debts (+€51,590) and Stocks and contracts (+€9,299)

  • Tangible fixed assets -€2,914

    down €2,914 (-18.4%), from €15,816 to €12,902

    of which Plant, machinery and equipment: -€1,467

  • Deferred charges and accrued income -€1,913

    down €1,913 (-74.9%), from €2,555 to €642

Equity and liabilities
  • Trade debts -€66,983

    down €66,983 (-39.5%), from €169,465 to €102,482

  • Other debts +€51,590

    up €51,590 (+8.4%), from €610,629 to €662,219

  • Profit (loss) carried forward -€7,870

    down €7,870 (-0.7%), from -€1.1m to -€1.1m

  • Advances received +€3,024

    up €3,024, from €0 to €3,024

  • Tax, wage and social debts +€2,417

    up €2,417 (+45.4%), from €5,329 to €7,746

    of which Remuneration and social security: +€3,284

Income statement
  • Staff costs -€81,169

    down €81,169 (-64.7%), from €125,461 to €44,292

  • Gross operating margin -€16,168

    down €16,168 (-28.8%), from €56,184 to €40,016

  • Taxes -€15,851

    down €15,851, from €14,488 to -€1,363

  • Financial income +€2,235

    up €2,235 (+7676.5%), from €29 to €2,265

  • Depreciation -€2,099

    down €2,099 (-36.6%), from €5,738 to €3,640

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€103,436
Gross operating margin -€16,168
Staff costs +€81,169
Depreciation +€2,099
Other operating charges +€171
Other operating items +€10,948
Financial income +€2,235
Financial charges -€738
Taxes +€15,851
Result 2025 -€7,870

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€5,582
Investment -€107
Financing €0
Cash 2024 €22,263
Net result for the year -€7,870
Depreciation +€3,640
Stocks and contracts +€9,299
Receivables within one year +€8,553
Deferred charges and accrued income +€1,913
Trade debts -€66,983
Tax, wage and social debts +€2,417
Advances received +€3,024
Other debts +€51,590
Accrued charges and deferred income +€0
Investment in fixed assets (net) -€107
Cash 2025 €27,738
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €154,317 €136,494 -€17,822 -11.5%
Fixed assets 21/28 €16,541 €13,009 -€3,533 -21.4%
Intangible fixed assets 21 €725 €0 -€725 -100.0%
Tangible fixed assets 22/27 €15,816 €12,902 -€2,914 -18.4%
Plant, machinery and equipment 23 €9,936 €8,468 -€1,467 -14.8%
Furniture and vehicles 24 €5,881 €4,433 -€1,447 -24.6%
Financial fixed assets 28 - €107 +€107
Current assets 29/58 €137,775 €123,486 -€14,289 -10.4%
Stocks and contracts in progress 3 €74,950 €65,651 -€9,299 -12.4%
Stocks 30/36 €74,950 €65,651 -€9,299 -12.4%
Amounts receivable within one year 40/41 €38,007 €29,454 -€8,553 -22.5%
Trade receivables 40 €38,007 €26,884 -€11,124 -29.3%
Other amounts receivable 41 €0 €2,571 +€2,571
Cash at bank and in hand 54/58 €22,263 €27,738 +€5,476 +24.6%
Deferred charges and accrued income 490/1 €2,555 €642 -€1,913 -74.9%
Total equity and liabilities 10/49 €154,317 €136,494 -€17,822 -11.5%
Equity 10/15 -€631,107 -€638,978 -€7,870 -1.2%
Contributions 10/11 €455,000 €455,000 = 0.0%
Profit (loss) carried forward 14 -€1,086,107 -€1,093,978 -€7,870 -0.7%
Amounts payable 17/49 €785,424 €775,472 -€9,952 -1.3%
Amounts payable within one year 42/48 €785,424 €775,472 -€9,952 -1.3%
Trade debts 44 €169,465 €102,482 -€66,983 -39.5%
Suppliers 440/4 €169,465 €102,482 -€66,983 -39.5%
Advances received on contracts in progress 46 €0 €3,024 +€3,024
Taxes, remuneration and social security 45 €5,329 €7,746 +€2,417 +45.4%
Taxes 450/3 €867 €0 -€867 -100.0%
Remuneration and social security 454/9 €4,462 €7,746 +€3,284 +73.6%
Other amounts payable 47/48 €610,629 €662,219 +€51,590 +8.4%
Accrued charges and deferred income 492/3 - €0 +€0
Remuneration, social security and pensions 62 €125,461 €44,292 -€81,169 -64.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €5,738 €3,640 -€2,099 -36.6%
Other operating charges 640/8 €2,664 €2,493 -€171 -6.4%
Non-recurring operating charges 66A €10,948 €0 -€10,948 -100.0%
Gross operating margin 9900 €56,184 €40,016 -€16,168 -28.8%
Operating profit (loss) 9901 -€88,627 -€10,409 +€78,218 +88.3%
Financial income 75/76B €29 €2,265 +€2,235 +7676.5%
Recurring financial income 75 €29 €2,265 +€2,235 +7676.5%
Financial charges 65/66B €350 €1,089 +€738 +210.7%
Recurring financial charges 65 €350 €1,089 +€738 +210.7%
Profit (loss) for the period before taxes 9903 -€88,948 -€9,233 +€79,715 +89.6%
Income taxes 67/77 €14,488 -€1,363 -€15,851
Profit (loss) for the period 9904 -€103,436 -€7,870 +€95,566 +92.4%
Profit (loss) for the period to be appropriated 9905 -€103,436 -€7,870 +€95,566 +92.4%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.